Danaher (DHR) grants 10,172 RSUs and 26,767 options to SVP

Danaher Corporation (DHR) reported new equity awards to its Senior Vice President and General Counsel, Jonathan Leiken.

Rhea-AI Filing Summary

Danaher Corporation (DHR) reported new equity awards to its Senior Vice President and General Counsel, Jonathan Leiken. On November 15, 2025, he received 10,172 restricted stock units (RSUs) that are payable solely in common stock and were recorded at a price of $0 per share. One third of these RSUs vest on each of the first, second, and third anniversaries of the grant date. On the same date, he was also granted an employee stock option to purchase 26,767 shares of common stock at an exercise price of $221.21 per share, with one third of the options becoming exercisable on each of the first three anniversaries of November 15, 2025.

Insider Trade Summary

Grant/Award: 36,939 shares

Grant/Award 2 txns

Insider Leiken Jonathan

Role SVP- General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Employee stock option (right to buy)	26,767	$0.00	$0.00
Grant/Award	Common Stock	10,172	$0.00	$0.00

Holdings After Transaction: Employee stock option (right to buy) — 26,767 contracts (Direct); Common Stock — 10,172 shares (Direct)

Footnotes (2)

1. F1. On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One third of the RSUs vest on each of the first, second, and third anniversaries of the grant date, which is November 15, 2025.
2. F2. One third of the options granted become exercisable on each of the first three anniversaries of the grant date, which is November 15, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Danaher (DHR) report in this Form 4 filing?

The filing reports that Danaher granted equity awards to its SVP-General Counsel, Jonathan Leiken, including restricted stock units and stock options in Danaher common stock.

How many restricted stock units were granted to the Danaher (DHR) executive?

Jonathan Leiken was granted 10,172 restricted stock units (RSUs), which are payable solely in Danaher common stock and were reported at a price of $0 per share.

What stock options were granted in this Danaher (DHR) Form 4?

He received an employee stock option covering 26,767 shares of Danaher common stock, with an exercise price of $221.21 per share and an expiration date of November 15, 2035.

What is the vesting schedule for the Danaher (DHR) RSUs granted?

For the RSUs, one third of the 10,172 units vests on each of the first, second, and third anniversaries of the November 15, 2025 grant date.

What is the vesting schedule for the Danaher (DHR) stock options granted?

For the stock options, one third of the 26,767 options becomes exercisable on each of the first three anniversaries of the grant date, November 15, 2025.

Who is the reporting person in this Danaher (DHR) Form 4 and what is their role?

The reporting person is Jonathan Leiken, who serves as SVP–General Counsel of Danaher Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leiken Jonathan

(Last) (First) (Middle)

2200 PENNSYLVANIA AVE NW

SUITE 800W

(Street)

WASHINGTON DC 20037

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP- General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/15/2025		A		10,172(1)	A	$0	10,172	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	$221.21	11/15/2025		A		26,767		(2)	11/15/2035	Common Stock	26,767	$0	26,767	D

Explanation of Responses:

1. On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One third of the RSUs vest on each of the first, second, and third anniversaries of the grant date, which is November 15, 2025.

2. One third of the options granted become exercisable on each of the first three anniversaries of the grant date, which is November 15, 2025.

Remarks:

	/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.